⌘K

Login Start Free

Home/Filings/4/A/0001493152-23-003889

4/A//SEC Filing

Mack Anthony P. 4/A

Accession 0001493152-23-003889

CIK 0001708331other

View on SEC.gov Company Profile

Filed

Feb 6, 7:00 PM ET

Accepted

Feb 7, 9:30 PM ET

Size

5.7 KB

Accession

0001493152-23-003889

Insider Transaction Report

Form 4/AAmended

Period: 2023-01-25

Virpax Pharmaceuticals, Inc.VRPX

Mack Anthony P.

DirectorChief Executive Officer10% Owner

Transactions

Award
Stock Option (right to buy)
2023-01-25+125,000→ 125,000 total
Exercise: $0.87Exp: 2028-01-25→ Common Stock (125,000 underlying)

Footnotes (1)

[F1]The option vests in three equal annual installments commencing on January 25, 2024.

Documents

1 file

4
ownership.xml

Issuer

Virpax Pharmaceuticals, Inc.

CIK 0001708331

Entity typeother

Related Parties

1

filerCIK 0001818483

Filing Metadata

Form type: 4/A
Filed: Feb 6, 7:00 PM ET
Accepted: Feb 7, 9:30 PM ET
Size: 5.7 KB

View on SEC.gov